Essex Financial Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,101
Closed -$280K 641
2024
Q2
$280K Hold
4,101
0.02% 500
2024
Q1
$278K Hold
4,101
0.03% 437
2023
Q4
$253K Hold
4,101
0.03% 434
2023
Q3
$242K Hold
4,101
0.03% 412
2023
Q2
$245K Hold
4,101
0.03% 404
2023
Q1
$240K Hold
4,101
0.03% 429
2022
Q4
$254K Hold
4,101
0.03% 405
2022
Q3
$232K Hold
4,101
0.03% 400
2022
Q2
$262K Hold
4,101
0.03% 389
2022
Q1
$266K Buy
4,101
+801
+24% +$50.8K 0.03% 412
2021
Q4
$220K Hold
3,300
0.02% 455
2021
Q3
$201K Hold
3,300
0.02% 447
2021
Q2
$204K Buy
+3,300
New +$201K 0.03% 434
2018
Q2
Sell
-4,200
Closed -$207K 310
2018
Q1
$207K Buy
+4,200
New +$216K 0.04% 327
2016
Q2
Sell
-4,890
Closed -$223K 311
2016
Q1
$223K Hold
4,890
0.06% 269
2015
Q4
$264K Hold
4,890
0.06% 250
2015
Q3
$241K Buy
4,890
+1,020
+26% +$58.5K 0.06% 270
2015
Q2
$226K Hold
3,870
0.06% 288
2015
Q1
$222K Sell
3,870
-1,422
-27% -$77.8K 0.06% 286
2014
Q4
$267K Hold
5,292
0.07% 247
2014
Q3
$248K Hold
5,292
0.07% 246
2014
Q2
$238K Hold
5,292
0.07% 259
2014
Q1
$223K Hold
5,292
0.07% 253
2013
Q4
$208K Buy
+5,292
New +$199K 0.07% 259

Other funds holding IHE

Essex Financial Services's IHE Position: Q3 2024 in Review

Essex Financial Services sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2024, closing a stake of 4,101 shares — an estimated $280K sold.

Essex Financial Services first reported a position in IHE in Q4 2013 and held it in 24 quarters. The position peaked at $280K in Q2 2024. 143 funds tracked by Wall St. Rank hold IHE as of Q3 2024.

  • Essex Financial Services reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2024 after selling out during the quarter.
  • Essex Financial Services sold 4,101 iShares US Pharmaceuticals ETF shares in Q3 2024, an estimated $280K.
  • Essex Financial Services first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and held it in 24 quarters.
  • Essex Financial Services's iShares US Pharmaceuticals ETF position peaked at $280K in Q2 2024.
  • 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2024.

Based on Essex Financial Services's 13F filing for Q3 2024, filed 24 Oct 2024.